The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
nSEPIA aims to bring structure to an area long dominated by subjectivity
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
